Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients.

ABSTRACT:

Objectives

Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available.

Design

Retrospective, observational cohort.

Setting

Two mixed medical-surgical tertiary (30 beds) and secondary (22 beds) ICUs.

Patients

All critically ill adult coronavirus disease 2019 survivors treated with venovenous extracorporeal membrane oxygenation between March 10, and April 30, 2020.

Measurements and main results

The last available lung function and 6-minute walking tests, performed after a median of 178 days (ranges, 72-232 d) from ICU admission, were a

SUBMITTER: Ego A 

PROVIDER: S-EPMC8288889 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature